文献速递产科母胎医学

孕早期PLGF低但子痫前期预测风险正常者的母婴结局

Obstetric and neonatal outcomes in pregnancies with low levels of maternal serum placental growth factor but a normal predicted risk of pre-eclampsia at 11 to 13 weeks.
PubMed 文献 · Am J Obstet Gynecol MFM · 2026-04-09

英国回顾性队列研究纳入7342例单胎妊娠,按孕11–13周PLGF第1、3、5、10百分位分层,分析低PLGF且FMF算法预测PE低风险者的结局。结果显示此类孕妇PE、母体及新生儿并发症、死产风险无显著升高,但足月SGA风险轻度增加。

要点

  • PLGF低且PE预测低风险者,PE及母胎并发症风险无显著增加。
  • 低PLGF与足月SGA风险轻度相关,早产SGA无显著关联。
  • PLGF低且PE预测高风险者,所有不良结局风险显著增加。

核心结论

  • PLGF低但FMF筛查PE低风险者,PE、母体或新生儿并发症及死产风险无显著增加。
  • 低PLGF与足月SGA分娩存在关联,与早产SGA无显著关联。

研究设计与样本

  • 英国Epsom and St Helier NHS trust开展的回顾性队列研究。
  • 2022年1月至2024年4月共7466例单胎妊娠接受11–13周筛查,排除124例后7342例纳入分析。
  • 按PLGF第1、3、5、10百分位分层,并分为PE高危及低风险组。

主要发现

  • PLGF低且PE高风险者,所有不良结局风险显著增加。
  • PLGF低且PE低风险者,PE、母体 morbidity、新生儿 morbidity 或死产无显著关联。
  • PLGF低且PE低风险者,SGA<3rd百分位RR=1.78(1.26-2.52),SGA<10th百分位RR=1.47(1.17-1.85)。
  • SGA风险增加仅见于足月(>37周),早产SGA无显著关联。

关键数值与推荐

  • PLGF低水平切点采用第1、3、5、10百分位。

临床怎么用

  • 对PLGF低但FMF算法预测PE低风险者,可告知PE及母胎并发症风险无显著增加。
  • 仍需关注足月SGA分娩风险,适当加强胎儿生长监测。

局限性

  • 回顾性队列设计。
  • 单中心研究。
  • 原文摘要未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of our study was to determine if an isolated finding of a low concentration of maternal serum placental growth factor (PLGF) is associated with an increased risk of pregnancy complications, despite a predicted low-risk result following first-trimester combined screening for pre-eclampsia (PE) using the Fetal Medicine Foundation (FMF) algorithm. STUDY DESIGN: Setting: Epsom and St Helier NHS trust, London, UK. DESIGN: This was a retrospective cohort study analyzing available pregnancy outcomes for women who consented to combined screening for PE between January 2022 and April 2024. A total of 7466 singleton pregnancies were offered screening at 11 to 13 weeks' gestation and after excluding those that had miscarriage, termination or lost to follow-up (n=124), 7342 cases were included in the final analysis. We stratified cases according to different cutoffs for low levels of PLGF corresponding to the 1st, 3rd, 5th, and 10th centiles. The study group was divided into those who had a high or low risk score for PE following screening. The incidence of PE, delivery of a small for gestational age (SGA) neonate, and composite measures of maternal and neonatal morbidity were examined in the study groups. Statistical significance was assessed at a level of p<.05. RESULTS: Pregnancies with a low PLGF and a high risk for PE had a significantly increased risk of all adverse outcomes. In pregnancies with low PLGF but a low-risk for PE, there was no significant association or risk for developing PE, maternal morbidity, neonatal morbidity or stillbirth; there was a mild association of low PLGF with the risk of delivering an SGA neonate (SGA<3rd centile, relative risk [RR]=1.78 (1.26-2.52) and SGA<10th centile, RR=1.47 (1.17-1.85). However, the increased risk was only significant for term SGA (>37 weeks), not preterm SGA. CONCLUSION: Pregnancies with low levels of PLGF can reassured that there is no significantly increased risk of PE, maternal or neonatal complications, or stillbirth if the FMF risk for PE following combined screening is deemed to be low. There is an association with delivery of a term SGA neonate.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Golob E, Akolekar R, Jones S, et al. Obstetric and neonatal outcomes in pregnancies with low levels of maternal serum placental growth factor but a normal predicted risk of pre-eclampsia at 11 to 13 weeks. Am J Obstet Gynecol MFM. 2026. PMID: 41966401. doi:10.1016/j.ajogmf.2026.101966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。